Market open
Camp4 Therapeutics Corporation/$CAMP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Camp4 Therapeutics Corporation
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
Ticker
$CAMP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
55
ISIN
US13463J1016
Website
CAMP Metrics
BasicAdvanced
$42M
-
-$5.39
-
-
Price and volume
Market cap
$42M
52-week high
$5.74
52-week low
$1.61
Average daily volume
480K
Financial strength
Current ratio
8.023
Quick ratio
7.674
Long term debt to equity
9.226
Total debt to equity
15.441
Interest coverage (TTM)
-2,665.65%
Management effectiveness
Return on equity (TTM)
-115.06%
Valuation
Price to revenue (TTM)
13.367
Price to book
0.82
Price to tangible book (TTM)
0.82
Price to free cash flow (TTM)
-0.408
Growth
Revenue change (TTM)
331.43%
Earnings per share change (TTM)
-95.44%
CAMP News
AllArticlesVideos
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting
GlobeNewsWire·6 hours ago
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
GlobeNewsWire·3 days ago
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Camp4 Therapeutics Corporation stock?
Camp4 Therapeutics Corporation (CAMP) has a market cap of $42M as of May 16, 2025.
What is the P/E ratio for Camp4 Therapeutics Corporation stock?
The price to earnings (P/E) ratio for Camp4 Therapeutics Corporation (CAMP) stock is 0 as of May 16, 2025.
Does Camp4 Therapeutics Corporation stock pay dividends?
No, Camp4 Therapeutics Corporation (CAMP) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Camp4 Therapeutics Corporation dividend payment date?
Camp4 Therapeutics Corporation (CAMP) stock does not pay dividends to its shareholders.
What is the beta indicator for Camp4 Therapeutics Corporation?
Camp4 Therapeutics Corporation (CAMP) does not currently have a Beta indicator.